Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis
暂无分享,去创建一个
D. Behar | M. Indelman | R. Bergman | G. Richard | E. Sprecher | O. Topaz | S. Raimer | I. Zelikovic | Z. Khamaysi | Daniel L. Shurman | P. Ratajczak | D. Petronius | Arieh Metzker | Mordechai Mizrachi | Vered Friedman | Danny Petronius
[1] Y. Takeuchi,et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. , 2004, The Journal of clinical investigation.
[2] Di Chen,et al. MEPE has the properties of an osteoblastic phosphatonin and minhibin. , 2004, Bone.
[3] T. Craig,et al. Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. , 2003, The Journal of clinical investigation.
[4] L. Quarles,et al. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. , 2003, American journal of physiology. Endocrinology and metabolism.
[5] M. Levine,et al. Molecular pathogenesis of hypophosphatemic rickets. , 2002, The Journal of clinical endocrinology and metabolism.
[6] R. Kumar,et al. FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate. , 2001, Biochemical and biophysical research communications.
[7] S. Takeda,et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[8] E. Bennett,et al. cDNA cloning and expression of a novel human UDP-N-acetyl-alpha-D-galactosamine. Polypeptide N-acetylgalactosaminyltransferase, GalNAc-t3. , 1996, The Journal of biological chemistry.
[9] L Kruglyak,et al. Parametric and nonparametric linkage analysis: a unified multipoint approach. , 1996, American journal of human genetics.
[10] M. Daly,et al. Rapid multipoint linkage analysis of recessive traits in nuclear families, including homozygosity mapping. , 1995, American journal of human genetics.
[11] R. Slavin,et al. Familial Tumoral Calcinosis: A Clinical, Histopathologic, and Ultrastructural Study with an Analysis of its Calcifying Process and Pathogenesis , 1993, The American journal of surgical pathology.
[12] H. DeLuca,et al. Elevated serum calcitriol concentrations do not fall in response to hyperphosphatemia in familial tumoral calcinosis. , 1985, American journal of diseases of children.
[13] Y. Levy,et al. X-Linked Lymphoproliferative Syndrome: A New Kindred With Variable Phenotypic Expression , 1985 .
[14] M. Prince,et al. Hyperphosphatemic tumoral calcinosis: association with elevation of serum 1,25-dihydroxycholecalciferol concentrations. , 1982, Annals of internal medicine.
[15] R. Kumar,et al. The phosphatonin pathway: new insights in phosphate homeostasis. , 2004, Kidney international.
[16] Lawrence A Tabak,et al. All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. , 2003, Glycobiology.